Visit Diabetes News from dLife.com

Class Of Diabetes Drugs Carries Significant Cardiovascular Risks

Posted on August 28, 2008

August 28, 2008 (EurekAlert) - A class of oral drugs used to treat type 2 diabetes may make heart failure worse, according to an editorial published online in Heart Wednesday by two Wake Forest University School of Medicine faculty members. We strongly recommend restrictions in the use of thiazolidinediones (the class of drugs) and question the rationale for leaving rosiglitazone on the market, write Sonal Singh, M.D., M.P.H., assistant professor of internal medicine, and Curt D. Furberg, M.D., Ph.D., professor of public health sciences. Rosiglitazone and pioglitazone are the two majo...

Original article link


cardiovascular disease , cholesterol , congestive heart failure , diabetes , heart disease , high blood pressure , type 2 diabetes